ANEBULO PHARMACEUTICALS, INC. (ANEB) Operating cash flow 2021–2025
ANEBULO PHARMACEUTICALS, INC. (ANEB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$6.3MFY2025 · since FY2021: -$4.9M → -$6.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.3M | +21.5% |
| FY2024 | -$8.1M | +16.4% |
| FY2023 | -$9.7M | -78.1% |
| FY2022 | -$5.4M | -11.6% |
| FY2021 | -$4.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice